Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06332040 · ClinicalTrials.gov registry record · Phase 4
Gentamicin Bladder Instillation on CAUTI
A Phase 4 study of Catheter Infection, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06332040: Recruiting Phase 4 study of Catheter Infection, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
NCT06332040 is a Phase 4 study of Catheter Infection that is actively recruiting participants, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 400 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06332040, a Phase 4 study of Catheter Infection, is actively recruiting participants, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Urinary tract infections in catheterized patients is an unacceptable complication and has been termed a 'never event' by the Center for Medicare \& Medicaid Services (CMS); however there is not consensus among clinicians on how to best prevent CAUTIs. We propose a prospective randomized controlled trial to test the efficacy of prophylactic gentamicin bladder irrigation in elimination of CAUTIs.
Primary Outcome
positive urine culture
Conditions Studied
Interventions
- DRUG Gentamicin
Study Locations (1)
Arizona
- St. Jpseph's Hospital and Medical Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-10-09 |
| Est. Completion | 2026-10-08 |
| Phase | Phase 4 |
What NCT06332040 shows while recruiting
NCT06332040 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Catheter Infection appearing as the primary indexed condition, and to 1 intervention - of which Gentamicin is the first listed.
NCT06332040 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06332040 about?
NCT06332040 is a clinical study titled "Gentamicin Bladder Instillation on CAUTI". Urinary tract infections in catheterized patients is an unacceptable complication and has been termed a 'never event' by the Center for Medicare \& Medicaid Services (CMS); however there is not consensus among clinicians on how to best prevent CAUTIs. We propose a prospective randomized controlled t...
What is the current status of trial NCT06332040?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2023-10-09. Estimated completion is 2026-10-08.
What conditions does trial NCT06332040 study?
This clinical trial studies the following conditions: Catheter Infection.
What interventions are being tested in trial NCT06332040?
The interventions under investigation include: Gentamicin (DRUG).
Who is sponsoring clinical trial NCT06332040?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06332040 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheter Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06332040's enrollment target sits among peer trials
400 211th of 2000 higher than 1,785 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI